Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
2,850,581
-
Total 13F shares
-
1,153,141
-
Share change
-
+1,153,141
-
Total reported value
-
$2,826,000
-
Price per share
-
$2.45
-
Number of holders
-
10
-
Value change
-
+$2,826,017
-
Number of buys
-
10
Institutional Holders of Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) as of Q1 2022
As of 31 Mar 2022 Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) had 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,153,141 shares of stock of the company.
Largest 10 holders included ARMISTICE CAPITAL, LLC, Empery Asset Management, LP, GEODE CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, TWO SIGMA SECURITIES, LLC, JANE STREET GROUP, LLC, Tower Research Capital LLC (TRC), UBS Group AG, NATIONAL BANK OF CANADA /FI/, and SIGNATUREFD, LLC.
This table shows 11 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.